GSK3B and hepatocellular carcinoma: For example, disulfiram–Cu enhances PD-L1 levels in hepatocellular carcinoma (HCC) cells by inhibiting PARP1 and promoting GSK-3β phosphorylation, which reduces T-cell infiltration.